Study on the neuroimmunological mechanism of postherpetic neuralgia (PHN)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031518

Enrollment

Unknown

Registered

2020-04-03

Start date

2018-06-01

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postherpetic neuralgia

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Meet PHN diagnostic criteria, duration of disease >= 1 month, aged >= 50 years, NRS >= 6 points before treatment.

Exclusion criteria

Exclusion criteria: 1. Recently used immunosuppressive drugs or hormones; 2. have other immune system diseases; 3. have malignant tumors; 4. have serious bacterial infections; 5. have diabetic neuralgia or nerve damage caused by drugs and trauma; 6. have mental illness and uncooperative.

Design outcomes

Primary

Measure	Time frame
microRNA;BDNF;IL-17;IL-10;	—

Countries

China

Contacts

Public Contactwang Lina

The First Affiliated Hospital of Soochow University

wangln@suda.edu.cn+86 13915400622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026